Ligand Pharmaceuticals announced its senior management will participate in two major investor events in June 2026: the Stifel Boston Cross Sector 1x1 Conference on June 3 and the Goldman Sachs 47th Annual Global Healthcare Conference on June 10. These appearances include one-on-one investor meetings and a fireside chat, providing opportunities to discuss Ligand's business and growth prospects. Ligand is known for managing a large portfolio of biopharmaceutical royalties and supporting drug development through proprietary technologies. Investors interested in meetings are advised to contact their representatives.
Corporate Insight's report reveals significant differences in virtual assistant performance across eight retirement plan recordkeepers. Fidelity and Voya received top marks for delivering real-time account data, strong natural language processing, an...
Broadcom announced a partnership with Samsung to release the first integrated 5G and Wi-Fi 8 fixed wireless access platform, aiming to improve broadband reliability and efficiency. The company also introduced new Wi-Fi 8 chips for home routers and pa...
Dycom Industries' stock surged 27.95% following its first-quarter report showing a 56.1% year-over-year rise in contract revenue to $1.97 billion, surpassing analyst expectations. The company also raised its fiscal 2027 revenue guidance to $7.38-$7.6...
Imagine, a brand experience firm, has partnered with Bojangles to redesign and enhance the restaurant experience across multiple locations. The collaboration focused on aligning brand strategy with physical design elements like décor and signage to c...
Salesforce, Snowflake, Marvell, and HP are set to report earnings, providing a broad view of AI demand across enterprise software, data cloud, custom silicon, and PCs. Investors are watching for signs that AI-related products and services are driving...
